The Journal of Urology
Volume 182, Issue 5 , Pages 2330-2333, November 2009

Impact of Urine Sodium on Urine Risk Factors for Calcium Oxalate Nephrolithiasis

  • Brian H. Eisner

      Affiliations

    • Corresponding Author InformationCorrespondence: Department of Urology, University of California-San Francisco, 400 Parnassus Ave., Suite A-610, San Francisco, California 94143 (telephone: 415-353-2200; FAX: 415-353-2480)
    • Financial interest and/or other relationship with Boston Scientific.
  • ,
  • Michael L. Eisenberg
  • ,
  • Marshall L. Stoller

      Affiliations

    • Financial interest and/or other relationship with Percsys.

Department of Urology, University of California-San Francisco, San Francisco, California

Received 26 February 2009 published online 16 September 2009.

Purpose

Increased sodium intake is thought to promote nephrolithiasis by dietary sodium hypercalciuric effects. However, equivocal data exist on whether increased urine sodium actually increases the nephrolithiasis risk. We examined the relationship between urine sodium and urine risk factors for nephrolithiasis.

Materials and Methods

We retrospectively reviewed the records of 880 patients evaluated at a metabolic stone clinic to determine the relationship between urine sodium and urine calcium, volume and calcium oxalate supersaturation. Patients were separated into sodium excretion quintiles. Tests of linear trend were performed by examining the linear contrast in coefficients and using Cuzick's nonparametric linear trend test. Multivariate linear regression with urine sodium as a continuous variable was done to assess the relationship between urine sodium and other urine variables.

Results

Tests of linear trend showed that urine calcium and volume increased with increasing urine sodium (each p <0.01) but urine calcium oxalate supersaturation decreased with increasing urine sodium (p <0.01). Multivariate linear regression was adjusted for age, sex, body mass index and urine constituents. Urine sodium was positively associated with urine calcium (β = 0.28, 95% CI 0.15 to 0.41, p <0.001) but negatively associated with urine calcium oxalate supersaturation (β = −0.013, 95% CI −0.016 to −0.011, p <0.001). There was a trend toward a positive association of urine sodium and volume (β = 0.001, 95% CI −0.00019 to 0.002, p = 0.10).

Conclusions

Increasing urine sodium does not appear to increase the risk of calcium oxalate nephrolithiasis. Global sodium restriction may not necessarily alter the risk of stone formation, ie cause changes in calcium oxalate urine supersaturation, in patients with a history of nephrolithiasis.

Key Words: kidney, sodium, nephrolithiasis, calcium oxalate, risk

Abbreviations and Acronyms: BMI, body mass index, SSCaOx, urine calcium oxalate supersaturation

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Study received institutional review board approval.

 For another article on a related topic see page 2490.

PII: S0022-5347(09)01738-8

doi:10.1016/j.juro.2009.07.014

Refers to article:

  • Effect of Potassium Citrate Therapy on the Risk of Renal Stone Formation During Spaceflight , 17 September 2009

    Peggy A. Whitson, Robert A. Pietrzyk, Jeffrey A. Jones, Mayra Nelman-Gonzalez, Edgar K. Hudson, Clarence F. Sams
    The Journal of Urology November 2009 (Vol. 182, Issue 5, Pages 2490-2496)

The Journal of Urology
Volume 182, Issue 5 , Pages 2330-2333, November 2009